Ernest M Graham1,2, Allen D Everett2,3, Jean-Christophe Delpech4, Frances J Northington2,5. 1. Division of Maternal-Fetal Medicine, Department of Gynecology and Obstetrics. 2. Neurosciences Intensive Care Nursery program. 3. Division of Cardiology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland. 4. Department of Newborn Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. 5. Division of Neonatology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: The rapid progress in biomarker science is on the threshold of significantly changing clinical care for infants in the neonatal ICU. Infants with neonatal brain injuries will likely be the first group whose management is dramatically altered with point-of-care, rapidly available brain biomarker analysis. Providing an interim update on progress in this area is the purpose of this review. RECENT FINDINGS: Highlighted findings from the past 18 months of publications on biomarkers in neonatal brain injury include; Specific nonbrain markers of cardiac health and global asphyxia continue to provide information on brain injury after hypoxic-ischemic encephalopathy (HIE). Prediction of injury in the piglet hypoxia-ischemia model is improved with the use of a combination score of plasma metabolites. In a neonatal piglet model of perinatal hypoxia-ischemia, a systemic proinflammatory surge of cytokines has been identified after rewarming from therapeutic hypothermia. New biomarkers identified recently include osteopontin, activin A, neutrophil gelatinase-associated lipocalin, secretoneurin, Tau and neurofilament light protein. Brain-based biomarkers differ in their ability to predict short-term in-hospital outcomes and long-term neurologic deficits. SUMMARY: Neonatal brain biomarker research is currently in its very early development with major advances still to be made.
PURPOSE OF REVIEW: The rapid progress in biomarker science is on the threshold of significantly changing clinical care for infants in the neonatal ICU. Infants with neonatal brain injuries will likely be the first group whose management is dramatically altered with point-of-care, rapidly available brain biomarker analysis. Providing an interim update on progress in this area is the purpose of this review. RECENT FINDINGS: Highlighted findings from the past 18 months of publications on biomarkers in neonatal brain injury include; Specific nonbrain markers of cardiac health and global asphyxia continue to provide information on brain injury after hypoxic-ischemicencephalopathy (HIE). Prediction of injury in the piglet hypoxia-ischemia model is improved with the use of a combination score of plasma metabolites. In a neonatal piglet model of perinatal hypoxia-ischemia, a systemic proinflammatory surge of cytokines has been identified after rewarming from therapeutic hypothermia. New biomarkers identified recently include osteopontin, activin A, neutrophil gelatinase-associated lipocalin, secretoneurin, Tau and neurofilament light protein. Brain-based biomarkers differ in their ability to predict short-term in-hospital outcomes and long-term neurologic deficits. SUMMARY: Neonatal brain biomarker research is currently in its very early development with major advances still to be made.
Authors: Niamh M Denihan; Jennifer A Kirwan; Brian H Walsh; Warwick B Dunn; David I Broadhurst; Geraldine B Boylan; Deirdre M Murray Journal: J Cereb Blood Flow Metab Date: 2017-08-25 Impact factor: 6.200
Authors: Christopher S Ennen; Thierry A G M Huisman; William J Savage; Frances J Northington; Jacky M Jennings; Allen D Everett; Ernest M Graham Journal: Am J Obstet Gynecol Date: 2011-06-15 Impact factor: 8.661
Authors: Sudeepta K Basu; Jeffrey R Kaiser; Danielle Guffey; Charles G Minard; Ronnie Guillet; Alistair J Gunn Journal: Arch Dis Child Fetal Neonatal Ed Date: 2015-08-17 Impact factor: 5.747
Authors: Tamil S Anthonymuthu; Elizabeth M Kenny; Zachary E Hier; Robert S B Clark; Patrick M Kochanek; Valerian E Kagan; Hülya Bayır Journal: Exp Neurol Date: 2019-04-11 Impact factor: 5.330
Authors: Sandra Brooks; Barbara D Friedes; Frances Northington; Ernest Graham; Aylin Tekes; Vera J Burton; Gwendolyn Gerner; Jie Zhu; Raul Chavez-Valdez; Dhananjay Vaidya; Allen D Everett Journal: Pediatr Res Date: 2021-12-18 Impact factor: 3.953
Authors: Christopher A Lear; Michi Kasai; Paul P Drury; Joanne O Davidson; Etsuko Miyagi; Laura Bennet; Alistair J Gunn Journal: Pediatr Res Date: 2020-03-17 Impact factor: 3.756
Authors: William Schleif; Frances Hamblin; Allen D Everett; Ernest M Graham; Jennifer Cross; Christy Fernald; Robert Follett; Bryan Lopes; Denise Martinez; Hector Monforte; Jennifer Ross-Wilkinson; Austin Sellers; Sandra Brooks Journal: Biopreserv Biobank Date: 2021-01-21 Impact factor: 2.300
Authors: Antoinette Depoorter; Roland P Neumann; Christian Barro; Urs Fisch; Peter Weber; Jens Kuhle; Sven Wellmann Journal: Front Neurol Date: 2018-11-20 Impact factor: 4.003